Manhattan Scientifics Inc (MHTX)

[Sparroww]

From their recent filing.

Our technology has been proven in animal models using human cancer cells, in human trials using bone marrow biopsy samples, and is the subject of over 20 patent applications and 14 peer-reviewed publications. Our success will depend in part on its ability to obtain regulatory approvals required for human application of its technologies, both in the United States and other countries. There can be no assurance that such approvals will be obtained.

There is nothing in that statement that would lead you or anyone to state that " -"FDA approval would be a short process"
-"diagnostic as opposed to therapeutic FDA approval would be a short process'